Skip to main navigation Skip to search Skip to main content

A Human Pluripotent Stem Cell-based Platform to Study SARS-CoV-2 Tropism and Model Virus Infection in Human Cells and Organoids

  • Liuliu Yang
  • , Yuling Han
  • , Benjamin E. Nilsson-Payant
  • , Vikas Gupta
  • , Pengfei Wang
  • , Xiaohua Duan
  • , Xuming Tang
  • , Jiajun Zhu
  • , Zeping Zhao
  • , Fabrice Jaffré
  • , Tuo Zhang
  • , Tae Wan Kim
  • , Oliver Harschnitz
  • , David Redmond
  • , Sean Houghton
  • , Chengyang Liu
  • , Ali Naji
  • , Gabriele Ciceri
  • , Sudha Guttikonda
  • , Yaron Bram
  • Duc Huy T. Nguyen, Michele Cioffi, Vasuretha Chandar, Daisy A. Hoagland, Yaoxing Huang, Jenny Xiang, Hui Wang, David Lyden, Alain Borczuk, Huanhuan Joyce Chen, Lorenz Studer, Fong Cheng Pan, David D. Ho, Benjamin R. tenOever, Todd Evans, Robert E. Schwartz, Shuibing Chen

Research output: Contribution to journalArticlepeer-review

550 Scopus citations

Abstract

Yang et al. show that hPSC-derived cells and organoids provide valuable models to study SARS-CoV-2 tropism and to model COVID-19. They find that hPSC-derived pancreatic endocrine cells and human adult hepatocyte and cholangiocyte organoids are permissive to SARS-CoV-2 infection.

Original languageEnglish
Pages (from-to)125-136.e7
JournalCell Stem Cell
Volume27
Issue number1
DOIs
StatePublished - 2 Jul 2020

Keywords

  • SARS-CoV-2
  • alpha cells
  • beta cells
  • human pluripotent stem cells
  • liver organoids
  • pancreatic endocrine cells

Fingerprint

Dive into the research topics of 'A Human Pluripotent Stem Cell-based Platform to Study SARS-CoV-2 Tropism and Model Virus Infection in Human Cells and Organoids'. Together they form a unique fingerprint.

Cite this